GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Nha Trang Vaccines And Biological Products JSC (HSTC:BIO) » Definitions » LT-Debt-to-Total-Asset

Nha Trang Vaccines And Biological Products JSC (HSTC:BIO) LT-Debt-to-Total-Asset : 0.00 (As of . 20)


View and export this data going back to 2018. Start your Free Trial

What is Nha Trang Vaccines And Biological Products JSC LT-Debt-to-Total-Asset?

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. Nha Trang Vaccines And Biological Products JSC's long-term debt to total assests ratio for the quarter that ended in . 20 was 0.00.

Nha Trang Vaccines And Biological Products JSC's long-term debt to total assets ratio stayed the same from . 20 (0.00) to . 20 (0.00).


Nha Trang Vaccines And Biological Products JSC LT-Debt-to-Total-Asset Historical Data

The historical data trend for Nha Trang Vaccines And Biological Products JSC's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nha Trang Vaccines And Biological Products JSC LT-Debt-to-Total-Asset Chart

Nha Trang Vaccines And Biological Products JSC Annual Data
Trend
LT-Debt-to-Total-Asset

Nha Trang Vaccines And Biological Products JSC Semi-Annual Data
LT-Debt-to-Total-Asset

Nha Trang Vaccines And Biological Products JSC LT-Debt-to-Total-Asset Calculation

Nha Trang Vaccines And Biological Products JSC's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in . 20 is calculated as

LT Debt to Total Assets (A: . 20 )=Long-Term Debt & Capital Lease Obligation (A: . 20 )/Total Assets (A: . 20 )
=/
=

Nha Trang Vaccines And Biological Products JSC's Long-Term Debt to Total Asset Ratio for the quarter that ended in . 20 is calculated as

LT Debt to Total Assets (Q: . 20 )=Long-Term Debt & Capital Lease Obligation (Q: . 20 )/Total Assets (Q: . 20 )
=/
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Nha Trang Vaccines And Biological Products JSC  (HSTC:BIO) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.


Nha Trang Vaccines And Biological Products JSC LT-Debt-to-Total-Asset Related Terms

Thank you for viewing the detailed overview of Nha Trang Vaccines And Biological Products JSC's LT-Debt-to-Total-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Nha Trang Vaccines And Biological Products JSC Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
No. 26 Han Thuyen, Xuong Huan Ward, Khanh Hoa Province, Nha Trang City, VNM
Nha Trang Vaccines And Biological Products JSC engages in the production and trading of vaccines, serums, and biological products for human use. It also manufactures herbal medicines, functional foods, and cosmetics.